Response to Venables and Levell

J Invest Dermatol. 2024 Feb;144(2):415-416. doi: 10.1016/j.jid.2023.09.286. Epub 2023 Nov 15.

Authors

John Ferguson¹, Viktoria Eleftheriadou², John Nesnas³

Affiliations

¹ St John's Institute of Dermatology, Guys and St Thomas' Hospital, London, United Kingdom.
² Department of Dermatology, Walsall Manor Hospital NHS Trust, Birmingham, United Kingdom.
³ Pfizer, Tadworth, United Kingdom. Electronic address: John.Nesnas@pfizer.com.

PMID: 37977499
DOI: 10.1016/j.jid.2023.09.286

No abstract available

Keywords: Basal cell carcinoma; Melanoma; Primary care; Squamous cell carcinoma; Vitiligo.

MeSH terms

Carcinoma, Basal Cell*
Humans
Skin Neoplasms*